Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

43.91 +0.14 (+0.32%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
42 43 Next >
September 2022 Stock Considerations
Let’s take a look at my September stock considerations which are similar to recent considerations from one to four months ago. 
Via Talk Markets
SpringWorks Shares Pop After Expanded Multiple Myeloma Pact With GSK
 
Via Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
 
Via Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
 
Via Benzinga
Novartis Appoints Merck Executive As Research Head
 
Via Benzinga
GSK's Rare Blood Cancer Candidate Goes Under FDA Review
 
Via Benzinga
One Suit Down Out Of 3,000 Zantac Related Lawsuits, Says GSK
 
Via Benzinga
Why IDEAYA Biosciences Shares Plunging Today
 
Via Benzinga
GSK Confirms Rotavirus Vaccine Shortage, Hits Four African Countries: Report
 
Via Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
 
Via Benzinga
IDEAYA Achieves First Milestone In GSK Pact For Pol Theta Helicase Inhibitor Candidate
 
Via Benzinga
Is Sanofi A Buy, Despite Recent Stumbles?
Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions. 
Via MarketBeat
Topics Intellectual Property
Fighting Omicron: This Covid Vaccine Candidate Is Going After The Dangerous Mutation
 
Via Benzinga
Recent Stock Purchase August 2022
I just continue to have a long-term outlook, continue to invest, diversify my portfolio even more and just hold on. 
Via Talk Markets
Vir Biotech Shuns FDA Submission Plans For GSK-Partnered COVID-19 Treatment
 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 62 companies set new 52-week lows. 
Via Benzinga
Sanofi's Run Of Bad Luck Continues As Pharma Giant Tosses Out A Cancer Drug
Shares extended deep losses following a Zantac-inspired downturn last week. 
Via Investor's Business Daily
AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report
 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 31 companies hit new 52-week lows. 
Via Benzinga
ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Landmark Drug Pricing Reform Bill Passes Congress House
The U.S. House of Representatives voted 220-207 to pass new, wide-ranging legislation allowing Medicare drug price negotiations for the first time and capping seniors’ drug expenses to $2,000 per year... 
Via Benzinga
Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus
New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area. 
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 22 companies reached new 52-week lows. 
Via Benzinga
GSK, PFE, SNY Stocks Fall on Zantac Litigation
You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions. 
Via InvestorPlace
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
These companies are at the center of lawsuits claiming Zantac causes cancer. 
Via Investor's Business Daily
Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday, 52 stocks hit new 52-week lows. 
Via Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.